| Topic |
Supervisor |
| Chronic myeloproliferative neoplasms: from molecular pathogenesis to everyday treatment |
Dr.Demeter Judit (MTA doktora) |
| Hairy cell leukemia: state of teh art 2022/2023 |
Dr.Demeter Judit (MTA doktora) |
| Indications and risks of thrombopoietin analogue treatment in chronic immune thrombocytopenic purpura |
Dr.Demeter Judit (MTA doktora) |
| Rare hematolgical disorders: the role of early recognition in their treatment |
Dr.Demeter Judit (MTA doktora) |
| Autoimmun liver diseases (AIH, PBC, PSC), autoimmun register |
Kuczyné Dr.Folhoffer Anikó (PhD) |
| Hepatic osteopathy |
Kuczyné Dr.Folhoffer Anikó (PhD) |
| Liver transplantation in PSC associated with ulcerativ colitis |
Kuczyné Dr.Folhoffer Anikó (PhD) |
| Wilson’s disease – register, genetic background, treatment |
Kuczyné Dr.Folhoffer Anikó (PhD) |
| Non-invasiv tests for evaluation of liver disease severity and prognosis |
Kuczyné Dr.Folhoffer Anikó (PhD) |
| Hepatitis E |
Kuczyné Dr.Folhoffer Anikó (PhD) |
| Molecular genetic in hepatology |
Kuczyné Dr.Folhoffer Anikó (PhD) |
| New antiviral agents in hepatitis C |
Kuczyné Dr.Folhoffer Anikó (PhD) |
| Risk of bone fragility – methods for estimation and influence |
Dr. Horváth Csaba (MTA doktora) |
| Secondary osteoporosis |
Dr. Horváth Csaba (MTA doktora) |
| Epidemiology of chronic kidney disease and treatment options |
Dr.Pethő Ákos (PhD) |
| Screening and care for hereditary kidney diseases |
Dr.Pethő Ákos (PhD) |
| Prevention and detection of tubulointerstitial kidney diseases |
Dr.Pethő Ákos (PhD) |
| Types of kidney replacement therapies, types and formation of vascular access, long-term complications of kidney replacement therapies |
Dr.Pethő Ákos (PhD) |
| The utility of novel densitometric methods in patients with endocrine diseases. |
Dr.Mészáros Szilvia (PhD) |
| Late consequences of gestational diabetes |
Dr. Tabák Gy. Ádám (PhD) |
| Predictors of gestational diabetes |
Dr. Tabák Gy. Ádám (PhD) |
| Pajzsmirigy tumorok genetikai háttere |
Dr. Takács István (MTA doktora) |
| A D-vitamin onkológiai hatásai |
Dr. Takács István (MTA doktora) |
| Ritka csontbetegségek |
Dr. Takács István (MTA doktora) |
| Az osteoporosis modern kezelése |
Dr. Takács István (MTA doktora) |
| A csontanyagcsere betegségek diagnosztikája |
Dr. Takács István (MTA doktora) |
| A hypoparathyreosis diagnosztikája és kezelése |
Dr. Takács István (MTA doktora) |
| Genetic factors in the development of bone mass and loss |
Dr. Lakatos Péter András (MTA doktora) |
| Genetic background of thyroid cancers |
Dr. Lakatos Péter András (MTA doktora) |
| Diagnostics of prostate cancers |
Dr. Lakatos Péter András (MTA doktora) |
| Prevalence and clinical associations of electrolyte disorders (hyponatremia, mypomagnesemia) in a medical department |
Dr. Tislér András (PhD) |
| Lupus nephritis |
Dr. Tislér András (PhD) |
| Rapidly progressive nephritis |
Dr. Tislér András (PhD) |
| Heart failure and kidney disease |
Dr. Tislér András (PhD) |
| Investigation of ECG parameters in patients at high cardiovascular risk |
Dr. Horváth Viktor (PhD) |
| Investigation of echocardiographic parameters in patients with impaired glucose tolerance |
Dr. Horváth Viktor (PhD) |
| Investigation of Holter ECG parameters in patients with diabetic cardiomyopathy |
Dr. Horváth Viktor (PhD) |
| Investigation of diastolic dysfunction in diabetic cardiomyopathy |
Dr. Horváth Viktor (PhD) |
| Assessing the disease knowledge of diabetics by using questionnaires |
Dr. Horváth Viktor (PhD) |
| Assessing and monitoring the cardiological status of oncology patients |
Dr. Horváth Viktor (PhD) |
| Inflammatory bowel disease (IBD) etiopathogenesis and treatment options |
Dr. Iliás Ákos (PhD) Dr.Gönczi Lóránt |
| Haarzell-Leukämie (HZL): der Weg von Splenektomie durch Chemotheraputika zu den molekulär gezielten Behandlunsmöglichkeiten |
Dr.Demeter Judit (MTA doktora) |
| HZL und HZL variant: state of the art 2022/2023 tanévtől |
Dr.Demeter Judit (MTA doktora) |
| Epidemiologie der chronischen Nierenerkrankungen und die Behandlungsmöglichkeiten |
Dr.Pethő Ákos (PhD) |
| Autoimmunerkrankungen der Nieren |
Dr.Pethő Ákos (PhD) |
| Screening und Pflege bei erblichen Nierenerkrankungen |
Dr.Pethő Ákos (PhD) |
| Prävention von tubulointerstitiellen Nierenerkrankungen und mögliche Behandlungen |
Dr.Pethő Ákos (PhD) |
| Arten von Nierenersatztherapie, Bildung von Gefäßverbindungen, Langzeitkomplikationen |
Dr.Pethő Ákos (PhD) |
| Analyse von mikroRNS in pankreatischen neuroendokrinen Tumoren |
Dr.Igaz Péter (MTA doktora) |